HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Ophthalmic Cancers

Ophthalmic cancers refer to tumors that develop in the eye or its surrounding structures. These malignancies can affect various parts of the eye, including the retina, choroid, iris, ciliary body, and the orbit. Ocular cancers are relatively rare compared to other types of cancers, but they can have significant implications for vision and overall health. One of the most common forms of ophthalmic cancer is retinoblastoma, a childhood cancer that originates in the retina. This tumor can occur unilaterally or bilaterally and may lead to vision loss if not diagnosed and treated promptly. Additionally, melanoma can affect the uvea, comprising the choroid, iris, and ciliary body. Diagnosis of ophthalmic cancers often involves a combination of imaging studies, such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), along with a thorough ophthalmic examination. Treatment modalities depend on the type, size, and location of the tumor. Options may include surgery, radiation therapy, laser therapy, or a combination of these approaches. Early detection and intervention play a crucial role in managing ophthalmic cancers and preserving vision. Regular eye examinations, especially in individuals with a family history of ocular cancers or other predisposing factors, are essential for timely diagnosis and treatment. Collaborative efforts between ophthalmologists, oncologists, and other healthcare professionals are vital in providing comprehensive care for individuals affected by ophthalmic cancers. Despite their rarity, ophthalmic cancers demand attention due to their potential impact on vision and overall well-being. Ongoing research and advancements in diagnostic tools and treatment modalities aim to improve outcomes for individuals facing these challenging conditions. Regular eye screenings and awareness of risk factors contribute to the early detection and successful management of ophthalmic cancers, ultimately enhancing the quality of life for those affected.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp